Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Closes Whatman Buy, Adding Lab Technologies to Dx Portfolio

NEW YORK (GenomeWeb News) – General Electric’s GE Healthcare unit said today that it has closed its purchase of the lab filtration company Whatman.
 
GE Healthcare signed the £363 million ($713 million at the time) agreement to acquire Whatman in early February. 
 
Peter Ehrenheim, GE Healthcare’s president and CEO, said in a statement today that “combining the skills of the two companies will enable GE Healthcare to create strong added value for customers in biomedical and drug discovery research."
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.